Details for 2018732064

Up to date per 01.04.2026

Actions

Title / Product Name

ANWENDUNG VON ANTI CD70 ANTIKÖRPER ARGX-110, UM AKUTE MYELOID LEUKEMIE ZU BEHANDELN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018732064

EP Publication Number

3638696

E-Number

1663435

Language

PCT Number

EP18066144

Publication Date

22.04.2020 A

06.03.2024 B1

Registration Date

06.03.2024

AT Publication Date

15.03.2024

Application Date

18.06.2018

Registration Number

Priorities

16.06.2017

201709677

IPC

C07K 16/28 20060101AFI20181221BHEP

Maximum Duration of Protection

18.06.2038

Owner

argenx BVIndustriepark - Zwijnaarde 7 9052 Zwijnaarde (Gent)BE

University of BernVerwaltungsdirektion Hochschulstrasse 63012 BernCH

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

LEUPIN, Nicolasc/o argenx BVBA Industriepark Zwijnaarde 7 Building C B-9052 GentBE

VAN ROMPAEY, Lucc/o argenx BVBA Industriepark Zwijnaarde 7 Building C B-9052 GentBE

DE HAARD, Hansc/o argenx BVBA Industriepark Zwijnaarde 7 Building C B-9052 GentBE

OCHSENBEIN, AdrianBreitenrain 28 3032 HinterkappelenCH

RIETHER, CarstenGesellschaftsstrasse 44 3012 BernCH

Information about Fees